To further screen the lncRNAs involved in axitinib resistance, we then performed in vitro IC50 assays and found that silencing STX17-DT reduced the axitinib resistance of RCC cell lines most obviously (Figs. 2D, E and S2D–S2G). The gene discussed is STX17; the disease is renal cell carcinoma.